Xylyx Bio receives $1.125 million from multiple foundations to accelerate clinical translation of bioengineered human organs for life-saving transplantation
Funding supports translational development of bioengineered human lung grafts for clinical transplantation
BROOKLYN, N.Y., April 2, 2025 /PRNewswire/ -- Xylyx Bio, Inc., a regenerative medicine company, announced that it has received $1,000,000 from the Richard M. Bartlett Jr. Memorial Foundation and $125,000 from the Ilene Beal Foundation and Margaret Stewart Lindsay Foundation to support translational development of bioengineered human organs for clinical transplantation.
Funding is accelerating translational research and development of Xylyx's groundbreaking bioengineered human lung graft aimed at significantly increasing the number of organs available for transplantation.
"The Richard Bartlett Memorial Foundation is deeply committed to advancing solutions in the lung transplant field," said Dr. Loring Bartlett, Founder of the Richard M. Bartlett Jr. Memorial Foundation. "My husband Rick received two donor lung offers, but both times the lungs were too damaged to be used. If bioengineered lungs were available, Rick would have had a chance. Xylyx's innovative approach holds important potential to expand the pool of organs available for transplant and save patient lives."
"The Ilene Beal Foundation and Margarat S. Lindsay Foundation are proud to honor the memory and legacy of Ilene and Margarat through support of Xylyx's mission," said Brian Potts, Trustee. "Xylyx Bio's dedication to saving lives inspires us all. Together, we can create positive change for patients."
"We are thrilled to partner with the Richard M. Bartlett Jr. Memorial Foundation, the Ilene Beal Foundation, and the Margaret Stewart Lindsay Foundation as we take the next major steps toward realizing our vision of eliminating transplant waitlist mortality," said Andrea Nye, CEO of Xylyx Bio.
About Xylyx Bio: Xylyx Bio's mission is to save lives through the development of fully functional bioengineered organ grafts that address needs across solid organ transplantation.
About the Richard M. Bartlett Jr. Memorial Foundation: The Richard M. Bartlett Jr. Memorial Foundation supports entities engaged in charitable, educational, or scientific activities related to lung transplant.
About the Ilene Beal Foundation: The Ilene Beal Foundation promotes Ilene's core principles of hard work, high standards, service, graciousness, and abiding care for others.
About the Margaret Stewart Lindsay Foundation: The Margaret Stewart Lindsay Foundation honors Margaret's legacy through support of causes that reflect her big heart and support of those who do not give up in the face of challenges.
Contact
Xylyx Bio, Inc.
info@xylyxbio.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/xylyx-bio-receives-1-125-million-from-multiple-foundations-to-accelerate-clinical-translation-of-bioengineered-human-organs-for-life-saving-transplantation-302417354.html
SOURCE Xylyx Bio, Inc.